Atlas Trials

Disease Burden Transition of Mucormycosis in Hematologic Malignancies Population Across Covid 19 Era: a Single-center Comparative Analysis From China

Clinical trial NCT06900114 · COMPLETED

Trial details

NCT number
NCT06900114
Sponsor
Institute of Hematology & Blood Diseases Hospital, China
Status
COMPLETED
Study type
OBSERVATIONAL
MucormycosisHematologic MalignanciesCOVID-19
Start date
2025-02-08
Primary completion
2025-05-30
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.